Change search
ReferencesLink to record
Permanent link

Direct link
A retrospective evaluation of preoperative anemia in patients undergoing radical cystectomy for muscle-invasive urothelial urinary bladder cancer, with or without neoadjuvant chemotherapy
Umeå University, Faculty of Medicine, Department of Surgical and Perioperative Sciences, Urology and Andrology.
Umeå University, Faculty of Medicine, Department of Surgical and Perioperative Sciences, Urology and Andrology.
2016 (English)In: SpringerPlus, E-ISSN 2193-1801, Vol. 5, 1167Article in journal (Refereed) Published
Abstract [en]

BACKGROUND AND OBJECTIVE: Neoadjuvant chemotherapy (NAC) can be associated with anemia, which can lead to more perioperative blood transfusions (PBT). Usage of PBT is associated with worse oncological outcomes. We evaluated the prevalence of preoperative anemia (PA) and the effect on hemoglobin levels depending on surgery timing after NAC.

METHODS: A retrospective single-center study with 240 consecutive patients undergoing radical cystectomy (RC) between 2001 and 2014 for muscle-invasive urothelial carcinoma (MIBC). Anemia was defined according to the WHO classification (male ≤ 130 g/L, female ≤ 120 g/L). Multivariable logistical regression was used to identify factors associated with PA and Pearson correlation for evaluating the change in hemoglobin levels depending on surgery timing.

RESULTS: Overall, 128 (53.3 %) patients were anemic pre-RC and 87 (36.3 %) patients received NAC. In a multivariable analysis, age, receipt of NAC, female gender, and low BMI were independent predictors of PA. In patients receiving NAC, the time to surgery from the last NAC cycle was correlated with the change in hemoglobin levels between the initiation of NAC and surgery.

CONCLUSIONS: PA was common in patients undergoing RC for MIBC. Receipt of NAC was found to be a strong predictor of PA.

CLINICAL MESSAGE: The emerging treatment of cisplatin based neoadjuvant chemotherapy for muscle-invasive bladder cancer, confers an increased risk for preoperative anemia. In the management of this malignancy, preoperative anemia renders further attention and focus.

Place, publisher, year, edition, pages
Springer, 2016. Vol. 5, 1167
Keyword [en]
Urinary bladder neoplasms, Neoadjuvant therapy, Cisplatin, Anemia, Cystectomy
National Category
Urology and Nephrology
Identifiers
URN: urn:nbn:se:umu:diva-125461DOI: 10.1186/s40064-016-2865-2ISI: 000381637200007PubMedID: 27512626OAI: oai:DiVA.org:umu-125461DiVA: diva2:968705
Available from: 2016-09-12 Created: 2016-09-12 Last updated: 2016-09-13Bibliographically approved

Open Access in DiVA

fulltext(883 kB)11 downloads
File information
File name FULLTEXT01.pdfFile size 883 kBChecksum SHA-512
adfa5a9249d27137e784dcfefef1b0e45267b5da6d361a5be2f144f01fc24e1ba1780cdfb9eab39ac8dfe17767034636ddf6d34fcf12c92f40317bb16eb16bc8
Type fulltextMimetype application/pdf

Other links

Publisher's full textPubMed

Search in DiVA

By author/editor
Sherif, Amir
By organisation
Urology and Andrology
In the same journal
SpringerPlus
Urology and Nephrology

Search outside of DiVA

GoogleGoogle Scholar
Total: 11 downloads
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

Altmetric score

Total: 12 hits
ReferencesLink to record
Permanent link

Direct link